NCT05603897

Brief Summary

The purpose of this study is to compare two different screening tests for detecting dysphagia (difficulty swallowing) as well as the risk for aspiration (silent swallowing of liquids/solids into the lungs) in patients after an ischemic stroke (when a blood clot blocks or narrows an artery leading to the brain).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
6mo left

Started Apr 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
Apr 2024Nov 2026

First Submitted

Initial submission to the registry

October 28, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 3, 2022

Completed
1.4 years until next milestone

Study Start

First participant enrolled

April 5, 2024

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2026

Last Updated

April 29, 2026

Status Verified

September 1, 2025

Enrollment Period

2.7 years

First QC Date

October 28, 2022

Last Update Submit

April 23, 2026

Conditions

Keywords

difficulty swallowing

Outcome Measures

Primary Outcomes (1)

  • Dysphagia measured by MASA

    The MASA is a 24-item clinical test that evaluates swallowing in the order in which swallowing phases occur. Each item is quantitatively scored using either a 5-point or 10-point score at the end of which a total score out of 200 is summed up. The MASA takes approximately 15-20 minutes to perform and can then be repeated during a patient's clinical course to monitor for recovery.

    Up to 20 minutes

Study Arms (2)

Mann Assessment of Swallowing Ability (MASA) Group

EXPERIMENTAL

Participants in this group will receive the MASA dysphagia screening once upon admission to inpatient rehabilitation for approximately 20 minutes.

Other: Mann Assessment of Swallowing Ability (MASA) (dysphagia screening tool)

Non-standardized clinical swallow evaluation Group

OTHER

Participants in this group will receive standard of care treatment (dysphagia screening once upon admission to inpatient rehabilitation using a non-standardized clinical swallow evaluation for approximately 15 minutes).

Other: Non-standardized clinical swallow evaluation

Interventions

Upon 1-2 days of admission to inpatient rehabilitation, the MASA will be administered for approximately 20 minutes during initial speech language pathology evaluation. The MASA will be administered at bedside as a cognitive/speech language evaluation as well as oropharyngeal function examination.

Mann Assessment of Swallowing Ability (MASA) Group

Participants will receive current standard of care for dysphagia screening and treatment.

Non-standardized clinical swallow evaluation Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults ≥ 18 years old
  • Patients admitted to Lynn Rehabilitation Center with an admitting diagnosis consistent with acute ischemic stroke within the past 1 month
  • Patients able to provide informed, written consent. If patients are not cognitively able to give informed consent, then consent will be obtained from patient proxy in person or over the phone
  • Able to read and comprehend verbal instruction in English and/or Spanish

You may not qualify if:

  • Adults \> 80 years old
  • Pregnant women
  • Prisoners
  • Those with a prior history of dysphagia
  • Those with any diagnoses that include acute intracranial hemorrhage, subdural hematoma, subarachnoid hemorrhage, traumatic brain injury

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lynn Rehabilitation Center / University of Miami

Miami, Florida, 33136, United States

RECRUITING

MeSH Terms

Conditions

Deglutition Disorders

Interventions

methyl N-acetylsibirosaminide

Condition Hierarchy (Ancestors)

Esophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic Diseases

Study Officials

  • Gemayaret Alvarez, MD

    University of Miami

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gemayaret Alvarez, MD

CONTACT

Claudia Santesteban-bidot, M.S.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending Physician

Study Record Dates

First Submitted

October 28, 2022

First Posted

November 3, 2022

Study Start

April 5, 2024

Primary Completion (Estimated)

November 30, 2026

Study Completion (Estimated)

November 30, 2026

Last Updated

April 29, 2026

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations